#pharmaceutical-industry

#pharmaceutical-industry

The chief executive of GSK yesterday declared the US to be the best place for pharmaceutical companies to invest. Emma Walmsley said the US led the world in launches of drugs and vaccines and, alongside China, was the best market for business development. She is the latest boss of a leading UK drugmaker to talk up business opportunities on the other side of the Atlantic, after AstraZeneca's Pascal Soriot hailed the vital importance of the US.

The obesity rate in the U.S. is continuing its downward trend. The news comes three years after obesity rates hit a record high. In 2022, almost four out of 10 (39.9%) of Americans met the threshold for the classification, however, the number first began to shrink in 2023. Now, the rate of obesity is now down to 37%, according to new data from Gallup.

The desire to stop your own tragedies from happening to someone else may be a strong motivator. However, the process of drug discovery has always been grindingly, gruelingly slow.

Ireland's position is that the treatment of pharma should be within negotiations with the EU on an agreement in principle, a crucial sector for our economy.

Anticipating early client shifts, Gopalakrishnan Mahadevan strategically guided his team to onboard techno-functional SMEs with relevant experience, strengthening the company's position for project support.

Hikma's generic Vascepa, with its "skinny label," poses a challenge for patent protection, potentially undermining the incentives for innovation in the pharmaceutical industry.

In 2004-2005, new regulations mandated full disclosure of clinical trial data, allowing independent researchers to analyze statins' primary data, revealing exaggerated benefits.

One policy advocate described the move as "a total capitulation to the demands of drug corporation lobbyists."